{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T11:20:42Z","timestamp":1783336842183,"version":"3.54.6"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s10067-023-06689-3","type":"journal-article","created":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T19:01:46Z","timestamp":1688238106000},"page":"2897-2903","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Real world experience with nintedanib in connective tissue disease-related interstitial lung disease: a retrospective cohort study"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6281-5705","authenticated-orcid":false,"given":"Marko","family":"Bare\u0161i\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8870-4704","authenticated-orcid":false,"given":"Sr\u0111an","family":"Novak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6188-0502","authenticated-orcid":false,"given":"Dijana","family":"Perkovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5884-1190","authenticated-orcid":false,"given":"Boris","family":"Karanovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6053-1469","authenticated-orcid":false,"given":"Filip","family":"Miri\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3473-8428","authenticated-orcid":false,"given":"Mislav","family":"Radi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4940-0577","authenticated-orcid":false,"given":"Branimir","family":"Ani\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,1]]},"reference":[{"key":"6689_CR1","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2147\/CLEP.S191418","volume":"11","author":"A Bergamasco","year":"2019","unstructured":"Bergamasco A, Hartmann N, Wallace L, Verpillat P (2019) Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease. Clin Epidemiol 11:257\u2013273. https:\/\/doi.org\/10.2147\/CLEP.S191418","journal-title":"Clin Epidemiol"},{"issue":"2","key":"6689_CR2","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1093\/rheumatology\/kex256","volume":"57","author":"BA Graney","year":"2018","unstructured":"Graney BA, Fischer A (2018) Advocating for early interstitial lung disease detection in mixed connective tissue disease. Rheumatology 57(2):204\u2013205. https:\/\/doi.org\/10.1093\/rheumatology\/kex256","journal-title":"Rheumatology"},{"key":"6689_CR3","doi-asserted-by":"publisher","unstructured":"Kadura S, Raghu G (2021) Rheumatoid arthritis-interstitial lung disease: Manifestations and current concepts in pathogenesis and management. Eur Respir Rev 30(160):210011. https:\/\/doi.org\/10.1183\/16000617.0011-2021","DOI":"10.1183\/16000617.0011-2021"},{"issue":"1","key":"6689_CR4","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.semarthrit.2020.11.009","volume":"51","author":"K-Y Sun","year":"2021","unstructured":"Sun K-Y, Fan Y, Wang Y-X, Zhong Y-J, Wang G-F (2021) Prevalence of interstitial lung disease in polymyositis and dermatomyositis: A meta-analysis from 2000 to 2020. Semin Arthritis Rheum 51(1):175\u2013191. https:\/\/doi.org\/10.1016\/j.semarthrit.2020.11.009","journal-title":"Semin Arthritis Rheum"},{"key":"6689_CR5","unstructured":"Luppi F, Sebastiani M, Silva M, Sverzellati N, Cavazza A, Salvarani C, Manfredi A (2020) Interstitial lung disease in Sj\u00f6gren\u2019s syndrome: a clinical review. Clin Exp Rheumatol 38 Suppl 126(4):291\u2013300"},{"issue":"8","key":"6689_CR6","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/S2213-2600(22)00223-5","volume":"10","author":"V Tzilas","year":"2022","unstructured":"Tzilas V, Tzouvelekis A, Ryu JH, Bouros D (2022) 2022 update on clinical practice guidelines for idiopathic pulmonary fibrosis and progressive pulmonary fibrosis. Lancet Respir Med 10(8):729\u2013731. https:\/\/doi.org\/10.1016\/S2213-2600(22)00223-5","journal-title":"Lancet Respir Med"},{"issue":"9","key":"6689_CR7","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","volume":"205","author":"G Raghu","year":"2022","unstructured":"Raghu G, Remy-Jardin M, Richeldi L, Thomson CC, Inoue Y, Johkoh T, Kreuter M, Lynch DA, Maher TM, Martinez FJ, Molina-Molina M, Myers JL, Nicholson AG, Ryerson CJ, Strek ME, Troy LK, Wijsenbeek M, Mammen MJ, Hossain T et al (2022) Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline. Am J Respir Crit Care Med 205(9):e18\u2013e47. https:\/\/doi.org\/10.1164\/rccm.202202-0399ST","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"6689_CR8","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1186\/s12890-021-01783-1","volume":"21","author":"JP Finnerty","year":"2021","unstructured":"Finnerty JP, Ponnuswamy A, Dutta P, Abdelaziz A, Kamil H (2021) Efficacy of antifibrotic drugs, nintedanib and pirfenidone, in treatment of progressive pulmonary fibrosis in both idiopathic pulmonary fibrosis (IPF) and non-IPF: a systematic review and meta-analysis. BMC Pulm Med 21(1):411. https:\/\/doi.org\/10.1186\/s12890-021-01783-1","journal-title":"BMC Pulm Med"},{"issue":"2","key":"6689_CR9","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1080\/14397595.2019.1696505","volume":"30","author":"M Kuwana","year":"2020","unstructured":"Kuwana M, Azuma A (2020) Nintedanib: new indication for systemic sclerosis-associated interstitial lung disease. Mod Rheumatol 30(2):225\u2013231. https:\/\/doi.org\/10.1080\/14397595.2019.1696505","journal-title":"Mod Rheumatol"},{"issue":"5","key":"6689_CR10","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s40265-021-01487-0","volume":"81","author":"YN Lamb","year":"2021","unstructured":"Lamb YN (2021) Nintedanib: a review in fibrotic interstitial lung diseases. Drugs 81(5):575\u2013586. https:\/\/doi.org\/10.1007\/s40265-021-01487-0","journal-title":"Drugs"},{"issue":"22","key":"6689_CR11","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","volume":"370","author":"L Richeldi","year":"2014","unstructured":"Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, Cottin V, Flaherty KR, Hansell DM, Inoue Y, Kim DS, Kolb M, Nicholson AG, Noble PW, Selman M, Taniguchi H, Brun M, Le Maulf F, Girard M et al (2014) Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med 370(22):2071\u20132082. https:\/\/doi.org\/10.1056\/NEJMoa1402584","journal-title":"N Engl J Med"},{"key":"6689_CR12","doi-asserted-by":"publisher","unstructured":"Distler O, Highland KB, Gahlemann M, Azuma A, Fischer A, Mayes MD, Raghu G, Sauter W, Girard M, Alves M, Clerisme-Beaty E, Stowasser S, Tetzlaff K, Kuwana M, Maher TM, SENSCIS Trial Investigators (2019) Nintedanib for systemic sclerosis-associated interstitial lung disease. N Engl J Med 380(26):2518\u20132528. https:\/\/doi.org\/10.1056\/NEJMoa1903076","DOI":"10.1056\/NEJMoa1903076"},{"issue":"18","key":"6689_CR13","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","volume":"381","author":"KR Flaherty","year":"2019","unstructured":"Flaherty KR, Wells AU, Cottin V, Devaraj A, Walsh SLF, Inoue Y, Richeldi L, Kolb M, Tetzlaff K, Stowasser S, Coeck C, Clerisme-Beaty E, Rosenstock B, Quaresma M, Haeufel T, Goeldner R-G, Schlenker-Herceg R, Brown KK (2019) Nintedanib in progressive fibrosing interstitial lung diseases. N Engl J Med 381(18):1718\u20131727. https:\/\/doi.org\/10.1056\/NEJMoa1908681","journal-title":"N Engl J Med"},{"issue":"4","key":"6689_CR14","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/art.21322","volume":"53","author":"SV Kocheril","year":"2005","unstructured":"Kocheril SV, Appleton BE, Somers EC, Kazerooni EA, Flaherty KR, Martinez FJ, Gross BH, Crofford LJ (2005) Comparison of disease progression and mortality of connective tissue disease-related interstitial lung disease and idiopathic interstitial pneumonia. Arthritis Rheum 53(4):549\u2013557. https:\/\/doi.org\/10.1002\/art.21322","journal-title":"Arthritis Rheum"},{"key":"6689_CR15","doi-asserted-by":"publisher","first-page":"283","DOI":"10.2147\/OARRR.S226695","volume":"11","author":"A Fischer","year":"2019","unstructured":"Fischer A, Patel NM, Volkmann ER (2019) Interstitial lung disease in systemic sclerosis: focus on early detection and intervention. Open Access Rheumatol 11:283\u2013307. https:\/\/doi.org\/10.2147\/OARRR.S226695","journal-title":"Open Access Rheumatol"},{"issue":"3","key":"6689_CR16","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/S2213-2600(20)30012-6","volume":"8","author":"CP Denton","year":"2020","unstructured":"Denton CP, Ong VH (2020) Challenges in evidence-based therapy for systemic sclerosis associated interstitial lung disease. Lancet Respir Med 8(3):226\u2013227. https:\/\/doi.org\/10.1016\/S2213-2600(20)30012-6","journal-title":"Lancet Respir Med"},{"issue":"5","key":"6689_CR17","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/acr2.11253","volume":"3","author":"FV Castelino","year":"2021","unstructured":"Castelino FV, Moua T (2021) Detection and management of interstitial lung diseases associated with connective tissue diseases. ACR Open Rheumatology 3(5):295\u2013304. https:\/\/doi.org\/10.1002\/acr2.11253","journal-title":"ACR Open Rheumatology"},{"issue":"12","key":"6689_CR18","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.3390\/biomedicines10123291","volume":"10","author":"M Radi\u0107","year":"2022","unstructured":"Radi\u0107 M, Novak S, Bare\u0161i\u0107 M, He\u0107imovi\u0107 A, Perkovi\u0107 D, Tekavec-Trkanjec J, Mayer M, Prus V, Morovi\u0107-Vergles J, Marasovi\u0107 Krstulovi\u0107 D, Cerovec M, Bulat Kardum L, Samar\u017eija M, Ani\u0107 B (2022) Delphi-Based Consensus on Interstitial Lung Disease Screening in Patients with Connective Tissue Diseases (Croatian National-Based Study). Biomedicines 10(12):3291. https:\/\/doi.org\/10.3390\/biomedicines10123291","journal-title":"Biomedicines"},{"key":"6689_CR19","doi-asserted-by":"publisher","unstructured":"Liang J, Cao H, Yang Y, Ke Y, Yu Y, Sun C, Yue L, Lin J (2021) Efficacy and tolerability of nintedanib in idiopathic-inflammatory-myopathy-related interstitial lung disease: a pilot study. Front Med 8:626953. https:\/\/doi.org\/10.3389\/fmed.2021.626953","DOI":"10.3389\/fmed.2021.626953"},{"key":"6689_CR20","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1136\/annrheumdis-2022-eular.2722","volume":"81","author":"C Bruni","year":"2022","unstructured":"Bruni C, Tofani L, Fretheim H, Liem S, Velauthapillai A, Bj\u00f8rkekj\u00e6r H et al (2022) POS0388 developing a screening tool for the detection of interstitial lung disease in systemic sclerosis: the ILD-RISC risk score. Ann Rheum Dis 81:449\u2013450","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"6689_CR21","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/S2213-2600(20)30330-1","volume":"9","author":"KB Highland","year":"2021","unstructured":"Highland KB, Distler O, Kuwana M, Allanore Y, Assassi S, Azuma A, Bourdin A, Denton CP, Distler JHW, Hoffmann-Vold AM, Khanna D, Mayes MD, Raghu G, Vonk MC, Gahlemann M, Clerisme-Beaty E, Girard M, Stowasser S, Zoz D, SENSCIS trial investigators. (2021) Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: A subgroup analysis of the SENSCIS trial. Lancet Respir Med 9(1):96\u2013106. https:\/\/doi.org\/10.1016\/S2213-2600(20)30330-1","journal-title":"Lancet Respir Med"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-023-06689-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-023-06689-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-023-06689-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T14:08:32Z","timestamp":1699884512000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-023-06689-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,1]]},"references-count":21,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["6689"],"URL":"https:\/\/doi.org\/10.1007\/s10067-023-06689-3","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,1]]},"assertion":[{"value":"2 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We declare that this manuscript is original, has not been published before, and is not currently being considered for publication elsewhere. We have no conflicts of interest associated with this publication and there has been no financial support for this work that could have influenced its outcome. As the corresponding author, I confirm that the manuscript has been read and approved for submission by all named authors with subsequent modifications. All authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}